| CTRI Number |
CTRI/2019/03/018099 [Registered on: 15/03/2019] Trial Registered Prospectively |
| Last Modified On: |
14/03/2019 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Treatment of Garbhashaya arbuda with Virechana,Lekhana Basti and oral therapy |
|
Scientific Title of Study
|
EFFECT OF VIRECHANA, LEKHANA BASTI AND ORAL THERAPY IN THE MANAGEMENT OF GARBHASHAYA ARBUDA W.S.R. TO UTERINE FIBROID -AN OPEN LABELLED SINGLE ARM CLINICAL TRIAL
|
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Gauravkumar Balat |
| Designation |
Ph D 1st year |
| Affiliation |
IPGT and RA |
| Address |
ROOM NO - 24,PG BOYS HOSTEL, IPGT & RA, GUJARAT AYURVEDA UNIVERSITY,361001 5TH FLOOR, PRASOOTI TANTRA AND STREE ROGA DEPARTMENT, IPGT & RA, GUJARAT AYURVED UNIVERSITY,361001 Jamnagar GUJARAT 361001 India |
| Phone |
9727528494 |
| Fax |
9727528494 |
| Email |
balatgaurav@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
PROF L P DEI |
| Designation |
PROF AND HOD OF PTSR DEPT AND DEAN IPGT AND RA |
| Affiliation |
IPGT AND RA |
| Address |
PROF. AND HOD OF PRASOOTI TANTRA AND STREE ROGA DEPARTMENT. 5TH FLOOR,IPGT AND RA,GUJARAT AYURVED UNIVERSITY,JAMNAGAR
GUJARAT
361008
India
PROF. AND HOD OF PRASOOTI TANTRA AND STREE ROGA DEPARTMENT. 5TH FLOOR,IPGT AND RA,GUJARAT AYURVED UNIVERSITY,JAMNAGAR
GUJARAT
361008
India
Jamnagar GUJARAT 361001 India |
| Phone |
9228198366 |
| Fax |
9228198366 |
| Email |
deilaxmipriya@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
PROF L P DEI |
| Designation |
PROF AND HOD OF PTSR DEPT AND DEAN IPGT AND RA |
| Affiliation |
IPGT AND RA |
| Address |
PROF. AND HOD OF PRASOOTI TANTRA AND STREE ROGA DEPARTMENT,5TH FLOOR,IPGT AND RA,
Jamnagar
GUJARAT
361008
India
PROF. AND HOD OF PRASOOTI TANTRA AND STREE ROGA DEPARTMENT,5TH FLOOR,IPGT AND RA,
Jamnagar
GUJARAT
361008
India
Jamnagar GUJARAT 361001 India |
| Phone |
9228198366 |
| Fax |
9228198366 |
| Email |
deilaxmipriya@yahoo.com |
|
|
Source of Monetary or Material Support
|
| Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar – 361008 |
|
|
Primary Sponsor
|
| Name |
INSTITUTE FOR POST GRADUATION TEACHING AND RESEARCH IN AYURVEDA |
| Address |
INSTITUTE FOR POST GRADUATION TEACHING AND RESEARCH IN AYURVEDA,GUJART AYURVED UNIVERSITY,OPP. CITY B POLICE STATION PN MARG JAMNAGAR,GUJARAT,361001 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DR GAURAVKUMAR R BALAT |
IPGT AND RA |
ROOM NO- 24,PG BOYS HOSTEL,GUJARAT AYURVEDA UNIVERSITY,JAMNAGAR,GUJARAT,361001 Jamnagar GUJARAT |
9727528494 9727528494 balatgaurav@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| INSTITUTIONAL ETHICS COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
patient with Garbhashaya arbuda uterine fibroid |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
NOT APPLICABLE |
NOT APPLICABLE |
| Intervention |
Single Group |
Enrolled patients fulfilling the criteria, consists of minimum 60 patients with uterine fibroid (Single group) will be given below total duration of treatments for four months.
1st month – Virechana karma,
2nd month – Oral therapy with varunadi kwatha 50ml per day and Lekhana Basti 345ml per day for 16 days,
3rd month – Oral therapy with varunadi kwatha 50ml per day
4th month – Oral therapy with varunadi kwatha 50ml per day
5th month – follow up
|
|
|
Inclusion Criteria
|
| Age From |
20.00 Day(s) |
| Age To |
50.00 Day(s) |
| Gender |
Female |
| Details |
1.Both married and unmarried patient Age group between 20year TO 50years.
2.Patients having fibroid size 5 cm and < 5cm as per USG report
3.Single or multiple fibroids
4.The patient either asymptomatic or having clinical signs and symptoms of uterine fibroid.
5.Women with Hb > 7 gm%
6.Patient are suitable (Yogya) for Basti and Virechana
|
|
| ExclusionCriteria |
| Details |
1.Patient <20 years and >50 years
2.Patient having fibroid size more than 5 cm as per USG report
3.Pregnant women with fibroid
4.Women with Hb < 7 gm%
5.Ovarian tumour, Tubo-ovarian mass and malignant tumours along with fibroid.
6.Patient with uncontrolled hypertension, tuberculosis, Diabetes Mellites and any other severe systemic disease.
7.Patients are not suitable (Yogya) for Basti and Virechana
8.Patients not willing to do Virechana and Basti
|
|
|
Method of Generating Random Sequence
|
Other |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
To explore, correlate and review of uterine Fibroid with Grabhashaya Arbuda in Ayurvedic parlance.
To develop a standard Ayurvedic treatment protocol for management of Grabhashaya Arbuda (Uterine fibroid)
|
Virechana,lekhana basti 16 days 1 cycle,varunadi kwatha for 3 month |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To evaluate & establish the efficacy of treatment protocol i.e Virechana Karma, Lekhana Basti and Oral therapy in the management of uterine fibroid(Garbhashaya Arbuda). |
Virechana,lekhana basti 16 days 1 cycle,varunadi kwatha for 3 month |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
18/03/2019 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
Non yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
Uterine fibroid, a noncancerous growth of the uterus also known as fibromyoma, leiomyoma or myoma,1, 2 that often appear during childbearing age most probably between 35-45 years in nulliparous or in those having one child infertility of female. It is the most common growth of the female genital tract. The aetiology, classification, pathogenesis, and management of Garanthi/Arbuda are discussed in detail in the Ayurveda texts. Mamsa Granthi/Arbuda (uterine fibroid) is a Bahu Doshjanya vyadhi which involve the AstamaAshaya (Grabhashya) and deeper Dhatus (mamsa dhatu and Artav) in the body. Considering all these points this study has been planned and included the treatment protocol i.e. Virechana, Lekhana Basti and oral therapy. Hence, the present clinical study; i.e. to evaluate the effect of Virechana karma, Lekhana Basti with Lekhaniya Maha kashaya and orally Varunadi Kwath on uterine fibroid. |